 |
Company Information
Fulcrum Pharma plc is an independent public company incorporated in the United Kingdom. The company offers a unique global strategic drug development and regulatory service to the pharmaceutical and biotechnology industries through offices in Europe, the USA and Japan. These services include the planning, design, execution and delivery of drug development programmes resulting in customised development solutions for client companies.
In compliance with Rule 26 of the AIM rules for Companies, the following information has been provided for the benefit of investors.
|
|
| Name |
Fulcrum Pharma plc |
| Place of Registration |
England |
| Registered Office Address |
Hemel One
Boundary Way
Hemel Hempstead
Hertfordshire
HP2 7YU |
| Company Registration Number |
3930927 |
| Country of Incorporation |
England |
| Main Country of Operation |
United Kingdom |
| Number of Securities in issue |
---177,587,802 Ordinary Shares of 1 pence each.
---There are no securities held in Treasury.
--- 25% of AIM securities in issue are not in public hands. |
| Percentage holdings of shareholders with 3% or more percent holdings |
NAME |
No.
SHARES |
% |
|
|
|
| BLUEHONE INVESTORS LLP |
25,117,986 |
14.14% |
| HSBC GLOBAL CUSTODY NOMINEE (UK) |
9,358,065 |
5.27% |
| PERSHING NOMINEES LIMITED |
9,347,743 |
5.26% |
| DR JONATHAN PETER COURT |
7,634,622 |
4.06% |
| DR GARETH ELPHINSTONE WALTERS |
6,992,995 |
3.94% |
| DR JAMES ALASTAIR DEVLIN |
7,093,975 |
3.93% |
| MR NEIL GRAHAM OUGHTON |
6,976,328 |
3.93% |
| RATHBONE NOMINEES LIMITED |
6,888,687 |
3.88% |
| MR CHRISTOPHER JAMES BROOKS |
6,516,667 |
3.67% |
| DR ROBERT MATTHEW MILLER |
6,476,328 |
3.65% |
| BARCLAYSHARE NOMINEES LIMITED |
6,275,973 |
3.53% |
| GILTSPUR NOMINEES LIMITED |
6,073,332 |
3.42% |
| TD WATERHOUSE NOMINEES (EUROPE) |
5,903,270 |
3.32% |
|
|
|
>> Back to Top
|
|
 |
Hemel One, Boundary Way, Hemel Hempstead, Herts HP2 7YU Company registration No. 3930927 | © Copyright 2009, Fulcrum Pharma plc
